High-resolution Mapping in Patients with Persistent AF

Código QR

High-resolution Mapping in Patients with Persistent AF

Guardado en:

Detalles Bibliográficos
Autores principales:	Marius Andronache, Nikola Drca, Graziana Viola
Formato:	article
Lenguaje:	EN
Publicado:	Radcliffe Medical Media 2019
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/c2d04a4a98e14e0d8711f2b08bf9d03c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

High-resolution Mapping in Patients with Persistent Atrial Fibrillation: A Case-based Review of the PENTARAYTM Catheter
por: Marius Andronache, et al.
Publicado: (2019)

Mapping and Imaging in Non-paroxysmal AF
por: Michael Ghannam, et al.
Publicado: (2019)

Long-term Outcome of Pulmonary Vein Isolation Versus Amiodarone Therapy in Patients with Coexistent Persistent AF and Congestive Heart Failure
por: Michela Faggioni, et al.
Publicado: (2020)

Direct Oral Anticoagulants Concentration Testing in Clinical Practice for High-Risk Patients with AF
por: K Pukite, et al.
Publicado: (2020)

High-power, Short-duration Radiofrequency Ablation for the Treatment of AF
por: Irum D Kotadia, et al.
Publicado: (2020)

Atrial Fibrosis: Translational Considerations for the Management of AF Patients
por: Stylianos Tzeis, et al.
Publicado: (2019)

AF in Cancer Patients: A Different Need for Anticoagulation?
por: Ana Pardo Sanz, et al.
Publicado: (2019)

Predictors of Recurrence of AF in Patients After Radiofrequency Ablation
por: Iskren Garvanski, et al.
Publicado: (2019)

The Evolving Role of Catheter Ablation in Patients With Heart Failure and AF
por: Sandeep Prabhu, et al.
Publicado: (2019)

Individualised Approaches for Catheter Ablation of AF: Patient Selection and Procedural Endpoints
por: Nicolas Johner, et al.
Publicado: (2019)

Challenges Associated with Interpreting Mechanisms of AF
por: Caroline H Roney, et al.
Publicado: (2020)

Relationship Between Obstructive Sleep Apnoea and AF
por: Ghanshyam Shantha, et al.
Publicado: (2019)

Understanding AF Mechanisms Through Computational Modelling and Simulations
por: Konstantinos N Aronis, et al.
Publicado: (2019)

Ivabradine and AF: Coincidence, Correlation or a New Treatment?
por: Mahmoud Abdelnabi, et al.
Publicado: (2020)

Rhythm Control in AF: Have We Reached the Last Frontier?
por: Gheorghe-Andrei Dan
Publicado: (2019)

Sleep Apnoea and AF: Where Do We Stand? Practical Advice for Clinicians
por: Suneet Mittal, et al.
Publicado: (2021)

Hybrid Convergent Procedure for the Treatment of Persistent and Long-standing Persistent Atrial Fibrillation
por: David B DeLurgio, et al.
Publicado: (2021)

Dynamic High-density Functional Substrate Mapping Improves Outcomes in Ischaemic Ventricular Tachycardia Ablation: Sense Protocol Functional Substrate Mapping and Other Functional Mapping Techniques
por: Nikolaos Papageorgiou, et al.
Publicado: (2021)

Investigating the efficacy of chest pressure for direct current cardioversion in atrial fibrillation: a randomised control trial protocol (Pressure-AF)
por: David Ferreira, et al.
Publicado: (2021)

Correction: CHARGE-AF in a national routineprimary care electronic health recordsdatabase in the Netherlands: validationfor 5-year risk of atrial fibrillation andimplications for patient selection inatrial fibrillation screening
Publicado: (2021)

Ventricular Tachycardia Isthmus Characteristics: Insights from High-density Mapping
por: Ruairidh Martin, et al.
Publicado: (2019)

Chronic thromboembolic pulmonary hypertension in patients with persistent chest symptoms after acute pulmonary embolism
por: Elif Sahutoglu, et al.
Publicado: (2021)

CHARGE-AF in a national routine primary care electronic health records database in the Netherlands: validation for 5-year risk of atrial fibrillation and implications for patient selection in atrial fibrillation screening
por: Ralf E Harskamp, et al.
Publicado: (2021)

Evaluating the Potential Effect of L-carnitine on the Prevention of AF Following Coronary Artery Bypass Graft Surgery: A Randomised Clinical Trial
por: F Dastan
Publicado: (2020)

Mobile Health for Cardiovascular Disease: The New Frontier for AF Management: Observations from the Huawei Heart Study and mAFA-II Randomised Trial
por: Yutao Guo, et al.
Publicado: (2020)

Clinical Utility of Body Surface Potential Mapping in CRT Patients
por: Ksenia Sedova, et al.
Publicado: (2021)

Persistent left vertical vein: An unusual cause of pulmonary hypertension and cirrhosis in a patient with hypertrophic obstructive cardiomyopathy
por: Umut Karabulut, et al.
Publicado: (2021)

Integrative analysis reveals essential mRNA, long non-coding RNA (lncRNA), and circular RNA (circRNA) in paroxysmal and persistent atrial fibrillation patients
por: Haoliang Sun, et al.
Publicado: (2021)

A Novel High-Resolution Surface Electrocardiographic Method to Identify and Characterize Myocardial Scar: A Proof-of-Concept Study
por: Derek S. Chew, MD, MSc, et al.
Publicado: (2021)

COVID-19: a patient with cardiovascular disease at high risk
por: Irina E. Chazova, et al.
Publicado: (2020)

Impact of Micro-, Mini- and Multi-Electrode Mapping on Ventricular Substrate Characterisation
por: Benjamin Berte, et al.
Publicado: (2020)

Cardiac resynchronization system implantation guided by three-dimensional electroanatomic mapping
por: Pedro Silva Cunha, et al.
Publicado: (2021)

Cardiac resynchronization system implantation guided by three-dimensional electroanatomic mapping
por: Pedro Silva Cunha, et al.
Publicado: (2021)

Mapping Technologies for Catheter Ablation of Atrial Fibrillation Beyond Pulmonary Vein Isolation
por: Giulio La Rosa, et al.
Publicado: (2021)

Decrement Evoked Potential Mapping to Guide Ventricular Tachycardia Ablation: Elucidating the Functional Substrate
por: Abhishek Bhaskaran, et al.
Publicado: (2020)

Perioperative myocardial damage and the incidence of type 2 myocardial infarction in patients with intermediate and high cardiovascular risk
por: Miraç Vural Keskinler, et al.
Publicado: (2021)

TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy Versus Ticagrelor Plus Aspirin Beginning at 3 Months in High-risk Patients Undergoing Percutaneous Coronary Intervention
por: Johny Nicolas, et al.
Publicado: (2020)

Prognostic value of CHA2DS2-VASc score in predicting high SYNTAX score and in-hospital mortality for non-ST elevation myocardial infarction in patients without atrial fibrillation
por: Mehmet Kadri Akboğa, et al.
Publicado: (2021)

Role of High-sensitivity Cardiac Troponin in Acute Coronary Syndrome
por: Mahesh Anantha Narayanan, et al.
Publicado: (2019)

The Role of Hemodynamic Support in High-risk Percutaneous Coronary Intervention
por: Charles Simonton, et al.
Publicado: (2020)